Literature DB >> 11286504

Galactose metabolism in mice with galactose-1-phosphate uridyltransferase deficiency: sucklings and 7-week-old animals fed a high-galactose diet.

C Ning1, R Reynolds, J Chen, C Yager, G T Berry, N Leslie, S Segal.   

Abstract

Mice deficient in galactose-1-phosphate uridyltransferase (GALT) demonstrate abnormal galactose metabolism but no obvious clinical phenotype. To further dissect the pathways of galactose metabolism in these animals, galactose oxidation and metabolite levels were studied in 16-day-old sucklings and the effect of a 4 week prior exposure to a 40% glucose or 40% galactose diet was determined in 7-week-old mice. Suckling GALT-deficient (G/G) mice slowly oxidized [1-14C]galactose to 14CO2, 4.0% of the dose when fed and 7.9% when fasted compared to normal animals 38.3 and 36.4% in 4 h, respectively. Plasma of G/G sucklings contained 11.1 mM galactose and erythrocyte galactose 1-phosphate levels were 28.2 and 31.9 mg/dl packed cells. Galactose, galactitol, galactonate, and galactose 1-phosphate were found in G/G suckling mouse tissues. The tissue galactose concentrations were 10% or less of that in plasma, suggesting that there was limited cellular entry of galactose. In 7-week-old fasted mice with 4 weeks prior exposure to glucose or galactose-containing diet, 4-h oxidation was 12.9 and 15.0% of the administered radiolabeled galactose, respectively. Normal animals oxidized 33.9 and 37.9% of the dose when fed the same diets, respectively. The ability of G/G mice to oxidize galactose in the absence of GALT activity suggests the presence of alternate metabolic pathways for galactose disposition. G/G mice fed the galactose-free 40% glucose diet had erythrocyte galactose 1-phosphate levels ranging from 6.4 to 17.7 mg/dl packed cells and detectable galactose and galactose metabolites in tissues, suggesting that these animals endogenously produced galactose. The plasma of 40% galactose-fed G/G mice contained 9.1 mM galactose with red blood cell galactose 1-phosphate averaging 43.6 mg/dl. Tissues of these animals also contained high levels of galactose and galactose 1-phosphate. Liver contained over 4 micromol/g galactonate but little galactitol. Despite the elevated galactose and galactose 1-phosphate, the animals tolerated the high-galactose diet and were indistinguishable from normal animals, exhibiting no manifestations of galactose toxicity seen in human GALT-deficient galactosemia. The data suggest that high galactose 1-phosphate levels do not cause galactose toxicity and that high galactitol in combination with galactose 1-phosphate may be a prerequisite. Absence of GALT appears necessary but insufficient to produce human galactosemic phenotype. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286504     DOI: 10.1006/mgme.2001.3152

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  11 in total

1.  Introduction to the Maastricht workshop: lessons from the past and new directions in galactosemia.

Authors:  Gerard T Berry; Louis J Elsas
Journal:  J Inherit Metab Dis       Date:  2010-11-30       Impact factor: 4.982

2.  A Drosophila melanogaster model of classic galactosemia.

Authors:  Rebekah F Kushner; Emily L Ryan; Jennifer M I Sefton; Rebecca D Sanders; Patricia Jumbo Lucioni; Kenneth H Moberg; Judith L Fridovich-Keil
Journal:  Dis Model Mech       Date:  2010-06-02       Impact factor: 5.758

3.  Subfertility and growth restriction in a new galactose-1 phosphate uridylyltransferase (GALT) - deficient mouse model.

Authors:  Manshu Tang; Anwer Siddiqi; Benjamin Witt; Tatiana Yuzyuk; Britt Johnson; Nisa Fraser; Wyman Chen; Rafael Rascon; Xue Yin; Harish Goli; Olaf A Bodamer; Kent Lai
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

4.  ARHI: A new target of galactose toxicity in Classic Galactosemia.

Authors:  K Lai; M Tang; X Yin; H Klapper; K Wierenga; Lj Elsas
Journal:  Biosci Hypotheses       Date:  2008

5.  Involvement of endoplasmic reticulum stress in a novel Classic Galactosemia model.

Authors:  Tatiana I Slepak; Manshu Tang; Vladlen Z Slepak; Kent Lai
Journal:  Mol Genet Metab       Date:  2007-07-20       Impact factor: 4.797

6.  Metabolic perturbations in classic galactosemia beyond the Leloir pathway: Insights from an untargeted metabolomic study.

Authors:  S Taylor Fischer; Allison B Frederick; ViLinh Tran; Shuzhao Li; Dean P Jones; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2019-01-22       Impact factor: 4.982

7.  Overelaborated synaptic architecture and reduced synaptomatrix glycosylation in a Drosophila classic galactosemia disease model.

Authors:  Patricia Jumbo-Lucioni; William Parkinson; Kendal Broadie
Journal:  Dis Model Mech       Date:  2014-10-17       Impact factor: 5.758

8.  Effects of Systemic Metabolic Fuels on Glucose and Lactate Levels in the Brain Extracellular Compartment of the Mouse.

Authors:  Alexandria Béland-Millar; Jeremy Larcher; Justine Courtemanche; Tina Yuan; Claude Messier
Journal:  Front Neurosci       Date:  2017-01-19       Impact factor: 4.677

Review 9.  Pathophysiology and targets for treatment in hereditary galactosemia: A systematic review of animal and cellular models.

Authors:  Minela Haskovic; Ana I Coelho; Jörgen Bierau; Jo M Vanoevelen; Laura K M Steinbusch; Luc J I Zimmermann; Eduardo Villamor-Martinez; Gerard T Berry; M Estela Rubio-Gozalbo
Journal:  J Inherit Metab Dis       Date:  2020-01-14       Impact factor: 4.982

Review 10.  Utilizing Organoid and Air-Liquid Interface Models as a Screening Method in the Development of New Host Defense Peptides.

Authors:  Ka-Yee Grace Choi; Bing Catherine Wu; Amy Huei-Yi Lee; Beverlie Baquir; Robert E W Hancock
Journal:  Front Cell Infect Microbiol       Date:  2020-05-20       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.